These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 23990383)
1. Acute promyelocytic leukemia: do we have a new front-line standard of treatment? Sanz MA; Iacoboni G; Montesinos P Curr Oncol Rep; 2013 Oct; 15(5):445-9. PubMed ID: 23990383 [TBL] [Abstract][Full Text] [Related]
2. Conventional induction and post-remission therapy in APL: have we arrived? Sanz MA; Iacoboni G; Montesinos P Best Pract Res Clin Haematol; 2014 Mar; 27(1):33-8. PubMed ID: 24907015 [TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide as first-line treatment for acute promyelocytic leukemia. Leu L; Mohassel L Am J Health Syst Pharm; 2009 Nov; 66(21):1913-8. PubMed ID: 19850784 [TBL] [Abstract][Full Text] [Related]
4. Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care. Iland HJ; Wei A; Seymour JF Best Pract Res Clin Haematol; 2014 Mar; 27(1):39-52. PubMed ID: 24907016 [TBL] [Abstract][Full Text] [Related]
5. How to manage acute promyelocytic leukemia. Mi JQ; Li JM; Shen ZX; Chen SJ; Chen Z Leukemia; 2012 Aug; 26(8):1743-51. PubMed ID: 22422168 [TBL] [Abstract][Full Text] [Related]
7. Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial. Iland HJ; Collins M; Bradstock K; Supple SG; Catalano A; Hertzberg M; Browett P; Grigg A; Firkin F; Campbell LJ; Hugman A; Reynolds J; Di Iulio J; Tiley C; Taylor K; Filshie R; Seldon M; Taper J; Szer J; Moore J; Bashford J; Seymour JF; Lancet Haematol; 2015 Sep; 2(9):e357-66. PubMed ID: 26685769 [TBL] [Abstract][Full Text] [Related]
8. Current treatment strategy of acute promyelocytic leukemia. Mi J Front Med; 2011 Dec; 5(4):341-7. PubMed ID: 22198746 [TBL] [Abstract][Full Text] [Related]
9. Treatment of acute promyelocytic leukemia without cytotoxic chemotherapy. Park JH; Tallman MS Oncology (Williston Park); 2011 Jul; 25(8):733-41. PubMed ID: 21874835 [TBL] [Abstract][Full Text] [Related]
10. ATRA plus arsenic gets another "A" in APL. Park JH Blood; 2012 Aug; 120(8):1535-6. PubMed ID: 22918418 [TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group. Adès L; Thomas X; Bresler AG; Raffoux E; Spertini O; Vey N; Marchand T; Récher C; Pigneux A; Girault S; Deconinck E; Gardin C; Tournilhac O; Lambert JF; Chevallier P; de Botton S; Lejeune J; Dombret H; Chevret S; Fenaux P Haematologica; 2018 Dec; 103(12):2033-2039. PubMed ID: 30026341 [TBL] [Abstract][Full Text] [Related]
12. What is the standard regimen for patients with acute promyelocytic leukemia? Lo-Coco F; Cicconi L Curr Hematol Malig Rep; 2014 Jun; 9(2):138-43. PubMed ID: 24729066 [TBL] [Abstract][Full Text] [Related]
13. Treatment of acute promyelocytic leukemia for older patients. Prebet T; Gore SD J Natl Compr Canc Netw; 2011 Mar; 9(3):337-42. PubMed ID: 21393443 [TBL] [Abstract][Full Text] [Related]
14. How I treat acute promyelocytic leukemia. Tallman MS; Altman JK Blood; 2009 Dec; 114(25):5126-35. PubMed ID: 19797519 [TBL] [Abstract][Full Text] [Related]
15. Progress in the treatment of acute promyelocytic leukemia: optimization and obstruction. Li J; Zhu H; Hu J; Mi J; Chen S; Chen Z; Wang Z Int J Hematol; 2014 Jul; 100(1):38-50. PubMed ID: 24938378 [TBL] [Abstract][Full Text] [Related]
16. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. Lo-Coco F; Avvisati G; Vignetti M; Thiede C; Orlando SM; Iacobelli S; Ferrara F; Fazi P; Cicconi L; Di Bona E; Specchia G; Sica S; Divona M; Levis A; Fiedler W; Cerqui E; Breccia M; Fioritoni G; Salih HR; Cazzola M; Melillo L; Carella AM; Brandts CH; Morra E; von Lilienfeld-Toal M; Hertenstein B; Wattad M; Lübbert M; Hänel M; Schmitz N; Link H; Kropp MG; Rambaldi A; La Nasa G; Luppi M; Ciceri F; Finizio O; Venditti A; Fabbiano F; Döhner K; Sauer M; Ganser A; Amadori S; Mandelli F; Döhner H; Ehninger G; Schlenk RF; Platzbecker U; ; ; N Engl J Med; 2013 Jul; 369(2):111-21. PubMed ID: 23841729 [TBL] [Abstract][Full Text] [Related]
17. Acute promyelocytic leukemia: from highly fatal to highly curable. Wang ZY; Chen Z Blood; 2008 Mar; 111(5):2505-15. PubMed ID: 18299451 [TBL] [Abstract][Full Text] [Related]
18. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy. Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642 [TBL] [Abstract][Full Text] [Related]
19. [Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: a systematic review and meta-analysis]. Xu SN; Chen JP; Liu JP; Xia Y Zhong Xi Yi Jie He Xue Bao; 2009 Nov; 7(11):1024-34. PubMed ID: 19912733 [TBL] [Abstract][Full Text] [Related]